Genetic background defines the regulation of postnatal cardiac growth by 17β-estradiol through a β-catenin mechanism

Endocrinology

Volumn 155, Issue 7, 2014, Pages 2667-2676

  Kararigas, Georgios ^a   Nguyen, Ba Tiep ^b,e   Zelarayan, Laura C ^c   Hassenpflug, Maike ^b   Toischer, Karl ^b   Sanchez Ruderisch, Hugo ^a   Hasenfuss, Gerd ^b   Bergmann, Martin W ^d   Jarry, Hubertus ^b   Regitz Zagrosek, Vera ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d DEPARTMENT OF CARDIOLOGY   (Germany)

^e VIETNAM NATIONAL UNIVERSITY OF AGRICULTURE   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; ESTRADIOL; GLYCOGEN SYNTHASE KINASE 3BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCYTOSIS; FEMALE; GENE EXPRESSION; GENETIC REGULATION; HEART CONTRACTION; HEART DEVELOPMENT; HEART MUSCLE; HISTOLOGY; HYBRIDIZATION; IMMUNOBLOTTING; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; POSTNATAL GROWTH; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; STUDENT T TEST; UPREGULATION; WILD TYPE;

ANIMALS; BETA CATENIN; CLUSTER ANALYSIS; ESTRADIOL; ESTROGENS; FEMALE; GENE ONTOLOGY; GENE REGULATORY NETWORKS; GLYCOGEN SYNTHASE KINASE 3; HEART; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIECTOMY; PHOSPHORYLATION; TRANSCRIPTOME;

EID: 84903288858     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-2180     Document Type: Article

References (53)

1. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest. 2006;116(3):561-570. (Pubitemid 43326860)
2. Acevedo ML, Kraus WL. Transcriptional activation by nuclear receptors. Essays Biochem. 2004;40:73-88. (Pubitemid 38901167)
3. Cheung E, Kraus WL. Genomic analyses of hormone signaling and gene regulation. Annu Rev Physiol. 2010;72:191-218.
4. McKenna NJ, O'Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell. 2002;108(4):465-474. (Pubitemid 34260872)
5. Hammes SR, Levin ER. Extranuclear steroid receptors: nature and actions. Endocr Rev. 2007;28(7):726-741. (Pubitemid 350294293)
6. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340(23):1801-1811. (Pubitemid 29266405)
7. Murphy E. Estrogen signaling and cardiovascular disease. Circ Res. 2011;109(6):687-696.
8. Patten RD, Pourati I, Aronovitz MJ, et al. 17β-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload. J Card Fail. 2008; 14(3):245-253. (Pubitemid 351434591)
9. Smith PJ, Ornatsky O, Stewart DJ, et al. Effects of estrogen replacement on infarct size, cardiac remodeling, and the endothelin system after myocardial infarction in ovariectomized rats. Circulation. 2000;102(24):2983-2989.
10. van Eickels M, Patten RD, Aronovitz MJ, et al. 17-β-estradiol increases cardiac remodeling and mortality in mice with myocardial infarction. J Am Coll Cardiol. 2003;41(11):2084-2092. (Pubitemid 36677136)
11. Kararigas G, Nguyen BT, Jarry H. Estrogen modulates cardiac growth through an estrogen receptor α-dependent mechanism in healthy ovariectomized mice. Mol Cell Endocrinol. 2014;382(2):909-914.
12. Nguyen BT, Kararigas G, Wuttke W, Jarry H. Long-term treatment of ovariectomized mice with estradiol or phytoestrogens as a new model to study the role of estrogenic substances in the heart. Planta Med. 2012;78(1):6 -11.
13. Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324(5923):98-102.
14. Kajstura J, Rota M, Cappetta D, et al. Cardiomyogenesis in the aging and failing human heart. Circulation. 2012;126(15):1869-1881.
15. Ahuja P, Sdek P, MacLellan WR. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev. 2007;87(2):521-544. (Pubitemid 47086282)
16. Clevers H. Wnt/β-catenin signaling in development and disease. Cell. 2006;127(3):469-480.
17. Gordon MD, Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem. 2006;281(32):22429-22433.
18. Hirotani S, Zhai P, Tomita H, et al. Inhibition of glycogen synthase kinase 3β during heart failure is protective. Circ Res. 2007;101(11):1164-1174. (Pubitemid 350146443)
19. Trivedi CM, Luo Y, Yin Z, et al. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity. Nat Med. 2007;13(3):324-331. (Pubitemid 46376684)
20. Haq S, Michael A, Andreucci M, et al. Stabilization of β-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci USA. 2003;100(8):4610-4615. (Pubitemid 36457778)
21. Chen X, Shevtsov SP, Hsich E, et al. The β-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophy. Mol Cell Biol. 2006;26(12):4462-4473. (Pubitemid 43877567)
22. Qu J, Zhou J, Yi XP, et al. Cardiac-specific haploinsufficiency of β-catenin attenuates cardiac hypertrophy but enhances fetal gene expression in response to aortic constriction. J Mol Cell Cardiol. 2007;43(3):319-326. (Pubitemid 47304446)
23. Zelarayán LC, Noack C, Sekkali B, et al. β-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proc Natl Acad Sci USA. 2008;105(50):19762- 19767.
24. Noack C, Zafiriou MP, Schaeffer HJ, et al. Krueppel-like factor 15 regulates Wnt/β-catenin transcription and controls cardiac progenitor cell fate in the postnatal heart. EMBO Mol Med. 2012;4(9):992-1007.
25. Böttner M, Christoffel J, Jarry H, Wuttke W. Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on pituitary function in rats. J Endocrinol. 2006;189(1):77-88. (Pubitemid 43670703)
26. Kararigas G, Becher E, Mahmoodzadeh S, Knosalla C, Hetzer R, Regitz-Zagrosek V. Sex-specific modification of progesterone receptor expression by 17β-oestradiol in human cardiac tissues. Biol Sex Differ. 2010;1(1):2.
27. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat. 1996;5:299-314.
28. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80.
29. Kararigas G, Bito V, Tinel H, et al. Transcriptome characterization of estrogen-treated human myocardium identifies myosin regulatory light chain interacting protein as a sex-specific element influencing contractile function. J Am Coll Cardiol. 2012;59(4):410-417.
30. Kararigas G, Fliegner D, Gustafsson JÅ, Regitz-Zagrosek V. Role of the estrogen/estrogen-receptor-β axis in the genomic response to pressure overload-induced hypertrophy. Physiol Genomics. 2011;43(8):438-446.
31. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 2002;18(suppl 1):S96-S104. (Pubitemid 41185642)
32. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249-264.
33. Gautier L, Cope L, Bolstad BM, Irizarry RA. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20(3):307-315. (Pubitemid 38262761)
34. Kauffmann A, Gentleman R, Huber W. arrayQualityMetrics - a bioconductor package for quality assessment of microarray data. Bioinformatics. 2009;25(3):415-416.
35. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3.
36. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267-273. (Pubitemid 36792858)
37. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545-15550. (Pubitemid 41528093)
38. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27-30. (Pubitemid 30047706)
39. Taelman VF, Dobrowolski R, Plouhinec JL, et al. Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell. 2010;143(7):1136-1148.
40. Babiker FA, De Windt LJ, van Eickels M, et al. 17β-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway. Circulation. 2004;109(2):269-276. (Pubitemid 38114150)
41. van Eickels M, Grohé C, Cleutjens JP, Janssen BJ, Wellens HJ, Doevendans PA. 17β-estradiol attenuates the development of pressure-overload hypertrophy. Circulation. 2001;104(12):1419-1423. (Pubitemid 32880156)
42. Xin HB, Senbonmatsu T, Cheng DS, et al. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature. 2002;416(6878):334-338.
43. Donaldson C, Eder S, Baker C, et al. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptordependent pathway that increases calcineurin degradation. Circ Res. 2009;104(2):265-275, 211p following 275.
44. Quintanilla RA, Muñoz FJ, Metcalfe MJ, et al. Trolox and 17β-estradiol protect against amyloid β-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway. J Biol Chem. 2005;280(12):11615-11625. (Pubitemid 40418475)
45. Zhang QG, Wang R, Khan M, Mahesh V, Brann DW. Role of Dickkopf-1, an antagonist of the Wnt/β-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation. J Neurosci. 2008;28(34):8430-8441.
46. Chandar N, Saluja R, Lamar PC, Kolman K, Prozialeck WC. P53 and β-catenin activity during estrogen treatment of osteoblasts. Cancer Cell Int. 2005;5:24.
47. Ge C, Yu M, Zhang C. G protein-coupled receptor 30 mediates estrogen-induced proliferation of primordial germ cells via EGFR/Akt/β- catenin signaling pathway. Endocrinology. 2012;153(7):3504-3516.
48. Mahmoodzadeh S, Eder S, Nordmeyer J, et al. Estrogen receptor α up-regulation and redistribution in human heart failure. FASEB J. 2006;20(7):926-934. (Pubitemid 44943950)
49. Simon MM, Greenaway S, White JK, et al. A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains. Genome Biol. 2013;14(7):R82.
50. Guo Y, Flaherty MP, Wu WJ, et al. Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and/or taken into account: results of a comprehensive analysis of determinants of infarct size in 1,074 mice. Basic Res Cardiol. 2012;107(5):288.
51. van den Borne SW, van de Schans VA, Strzelecka AE, et al. Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc Res. 2009;84(2):273-282.
52. Riley D, Dwinell M, Qian B, et al. Differences between three inbred rat strains in number of K+ channel-immunoreactive neurons in the medullary raphe nucleus. J Appl Physiol. 2010;108(4):1003-1010.
53. Margetts PJ, Hoff C, Liu L, et al. Transforming growth factor β-induced peritoneal fibrosis is mouse strain dependent. Nephrol Dial Transplant. 2013;28(8):2015-2027.